Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Dec 2025 07:00

RNS Number : 0875L
S & U PLC
11 December 2025
 

11 December 2025

S&U plc

("S&U" or "the Group")

TRADING STATEMENT

S&U PLC (LSE: SUS), the specialist motor and property finance lender today issues its trading update for the period 5th August 2025 to 10th December 2025.

 

Business Highlights

 

The turnaround in S&U's fortunes, predicted in our last trading statement of early August, and confirmed at our interim results in October, continues apace. Group profit at the end of the third quarter continues to beat budget. Trading, particularly at Advantage, our motor finance business, is healthy both in terms of new business volumes and quality. As a result, group net receivables, the life blood of future profitability, now stand at c.£491 m (2024: £447 m) and are accelerating month by month.

 

This surge clearly confirms the abilities of our businesses, once freed from the shackles of regulatory intervention. The lifting of the FCA's s166 process at Advantage in April, and the calming effect that the Supreme Court's sensible decisions on commission disclosure in early August have had on the wider industry, presage a firmer motor finance market. Indeed, the latest Finance and Leasing Association statistics show the used car finance market up by 6% in September, having declined slightly by 2% in the preceding months.

 

By comparison, the performance of both Advantage and Aspen has been remarkably resilient given the chaotic and monumentally mishandled recent budget, and its dampening effect on consumer confidence in general and more specifically on the housing market. Ironically, a happy consequence now appears to be a dawning realisation within the Treasury and the FCA that without growth and greater access to credit, consumer satisfaction and protection are pretty hypothetical.

 

Advantage Finance

The last four months have seen an upsurge in trading at Advantage, led by CEO Karl Werner. Recent monthly agreement volumes have averaged 2,500, or over £25m in value compared to 7,121 deals in the first half. Advantage's third quarter, to the 31st of October, saw a record 869,000 finance applications, and now receivables are a net c.£318m, an increase of 14% on the previous quarter.

 

This has given Advantage the opportunity to both improve its interest margins, especially amongst higher tier customers and, with a renewed scorecard and updated affordability measures, also improve the quality of its loan book. As a result, latest collection rates for November are at a record 93.4% of due. Recency statistics on collections are at their best level for two years. The very compliant way in which Advantage manages and guides its customers who fall into arrears is shown by the most recent figures on the number and size of successful repayment arrangements. In this way Advantage can assist its customers to protect and improve their credit ratings - an attribute too little recognised in the non-prime market.

 

We would encourage the Financial Conduct Authority to remember this when addressing industry concerns about its Commission Redress scheme which is currently under consultation. Advantage is only tangentially affected by this commission debate, having never employed discretionary commission

 

("DCAs"); or tied arrangements; Advantage estimates that only 2.4% of its customers even potentially qualify for redress consideration under the proposed rules. Nevertheless, in conjunction with the Finance and Leasing Association, Advantage has produced a comprehensive and constructive response to the FCA, which proposes reductions in scope of redress and a much more focused and efficient process.

 

Whatever the outcome, the company anticipates that the effect of commission redress upon Advantage's current robust trading performance will be minimal. Its strong rebound should continue unabated.

 

Aspen Bridging

 

Despite the drag on transactions in the residential property market caused by the government prevarication mentioned earlier, Aspen continues to sensibly grow its loan book. At half year net receivables stood at £148m. At the end of the period under review these are now c.£173m.

 

Repayments in the period were at £47m and year to date they are ahead of budget at £160m. Advances in the period were £75m, driven by a greater number of smaller deals for bridging products augmented by our very popular Buy to Let loans the average size of which is over £1.3m. Margins are stable and on budget. Application numbers were inevitably affected by drawn out budget speculation and then imposition of higher taxes on rental incomes, council tax extensions and a new mansion tax; however, these have rebounded in the last three weeks.

 

The quality of Aspen's loan book also remains good with just 16 out of 240 loans beyond term. Aspen is making steady progress on resolving the very small number of longer-term cases.

 

Although it is to be hoped that lower interest rates will produce a significant but unlikely revival in the UK's hidebound residential market, Aspen will nevertheless produce a solid second half and another good profit for the year as a whole.

 

Funding

 

The very welcome acceleration in activity throughout the Group of the past few months has seen Group net borrowings rise to £241m from £180m at the half year. Whilst the existing funding capacity of £280m will meet our requirements for the immediate future, an exciting project is at present under way to confirm substantially larger, but flexible, medium-term facilities on a competitive basis. These will facilitate the expansion we foresee for both businesses over the next three years.

 

Commenting on S&U's trading outlook, Anthony Coombs, S&U Chairman, said:

"Recent months have undoubtedly confirmed that S&U has regained its "Va Va Voom"; to quote my predecessor's habitual phrase. It is also true that investors are increasingly aware of the value inherent in family-controlled SME businesses with rewarding dividend policies. With both Advantage and Aspen on the right track, we have every confidence in the good rewards for shareholders we anticipate in the years to come".

 

 

 

 

 

For further information, please contact:

Enquiries

Anthony Coombs

S&U plc

c/o SEC Newgate

Financial Public Relations

Bob Huxford, Harry Handyside, Aqsa Ali

SEC Newgate

020 7653 9848

Broker

Andrew Buchanan, Rob Parker

Peel Hunt LLP

020 7418 8900

Broker

James Felix, John Welch, Daniel Gee-Summons

Berenberg

020 3207 7800

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRBDDCXBDGUG
Date   Source Headline
13th Apr 20174:24 pmRNSAnnual Financial Report
28th Mar 20177:00 amRNSFinal Results
10th Feb 20177:00 amRNSTrading Statement
19th Dec 20163:42 pmRNSDirector/PDMR Shareholding
14th Dec 201610:40 amRNSDirector/PDMR Shareholding
8th Dec 20167:00 amRNSTrading Statement
6th Dec 201611:26 amRNSDirector/PDMR Shareholding
29th Nov 201612:40 pmRNSDirector/PDMR Shareholdings
29th Nov 201610:47 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSBlock Listing Six Monthly Return
22nd Nov 20163:36 pmRNSExercise and Sale of Options
19th Oct 201612:43 pmRNSDirector/PDMR Shareholding
27th Sep 20167:00 amRNSHalf-year Report
5th Aug 20167:00 amRNSTrading Statement
26th Jul 20164:41 pmRNSSecond Price Monitoring Extn
26th Jul 20164:35 pmRNSPrice Monitoring Extension
8th Jul 201611:30 amRNSDirector/PDMR Shareholding
22nd Jun 201612:02 pmRNSPrice Monitoring Extension
16th Jun 20167:00 amRNSAnalyst Day 2016
9th Jun 201611:22 amRNSExercise and Sale of Options
27th May 20163:25 pmRNSDirector/PDMR Shareholding
26th May 20163:20 pmRNSBlock Listing Six Monthly Return
17th May 201612:41 pmRNSResult of AGM
17th May 20167:00 amRNSAGM Statement & Trading Update
3rd May 20169:13 amRNSTotal Voting Rights
15th Apr 20162:49 pmRNSAnnual Report and Accounts
13th Apr 20162:29 pmRNSExercise & Sale of Options/ Directors Shareholding
6th Apr 20164:49 pmRNSDirector/PDMR Shareholding
4th Apr 201612:38 pmRNSBlock Listing Application
22nd Mar 20167:00 amRNSAppointment of Non-Executive Director
22nd Mar 20167:00 amRNSPreliminary Results for Year Ended 31 January 2016
12th Feb 20167:00 amRNSTrading Update
15th Jan 20165:13 pmRNSDirector/PDMR Shareholding
23rd Dec 201511:06 amRNSRe: Options/ Directors' shareholding
11th Dec 20153:35 pmRNSDirector/PDMR Shareholding
10th Dec 20157:00 amRNSTrading Statement
23rd Nov 20157:00 amRNSBlocklisting Six Monthly Return
28th Sep 20155:33 pmRNSRe: Options/ Directors' Shareholding
22nd Sep 20157:00 amRNSHalf Yearly Report
5th Aug 20157:00 amRNSTrading Statement
4th Aug 20151:18 pmRNSCompletion of Disposal and Director Shareholding
3rd Aug 201512:00 pmRNSResult of General Meeting
9th Jul 20155:16 pmRNSPosting of Circular
7th Jul 201512:45 pmRNSDisposal
26th May 201512:54 pmRNSBlock Listing Application
26th May 201512:51 pmRNSBlocklisting Interim Review
21st May 20152:23 pmRNSAGM Statement
21st May 20157:00 amRNSInterim Management Statement
17th Apr 20157:00 amRNSAnnual Financial Report
1st Apr 201512:58 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.